Search results
Events
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Emicizumab Controls
Quality control of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Emicizumab Calibrator
Calibration of a modified one-stage FVIII activity assay for determination of active emicizumab concentration from a clot time measurement performed on an automated coagulation analyzer.
Edoxaban Calibrator (Lixiana®) Low
For the calibration of edoxaban measurements using anti-Xa chromogenic assays.
Edoxaban (Lixiana®) Control Low
For the quality control of edoxaban measurements using anti-Xa chromogenic assays.
Edoxaban (Lixiana®) Control
For the quality control of edoxaban measurements using anti-Xa chromogenic assays.
Edoxaban (Lixiana®) Calibrator
For the calibration of edoxaban measurements using anti-Xa chromogenic assays.
ELISA Dilution buffer, with albumin, pH 7.50
For immuno-enzymatic assays.
EASYPLASMA Control Set
Normal and abnormal control plasma. See list of parameters.